Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors.
about
Retroviral integration: Site matters: Mechanisms and consequences of retroviral integration site selectionResistance mutations outside the integrase coding region have an effect on human immunodeficiency virus replicative fitness but do not affect its susceptibility to integrase strand transfer inhibitorsPolymorphisms of HIV-2 integrase and selection of resistance to raltegravirHIV-1 integrase resistance among antiretroviral treatment naive and experienced patients from Northwestern Poland.HIV-1 group O integrase displays lower enzymatic efficiency and higher susceptibility to raltegravir than HIV-1 group M subtype B integraseTransmitted resistance to HIV integrase strand-transfer inhibitors: right on schedule.HIV-2 integrase polymorphisms and longitudinal genotypic analysis of HIV-2 infected patients failing a raltegravir-containing regimen.Role of raltegravir in the management of HIV-1 infection.Analysis of transmitted resistance to raltegravir and selective pressure among HIV-1-infected patients on a failing HAART in Sao Paulo, Brazil.Effect of HIV-1 Subtype C integrase mutations implied using molecular modeling and docking data.Lack of impact of pre-existing T97A HIV-1 integrase mutation on integrase strand transfer inhibitor resistance and treatment outcome.Prevalence of Integrase Strand Transfer Inhibitors (INSTI) Resistance Mutations in Taiwan.Role of raltegravir in HIV-1 management.From base pair to bedside: molecular simulation and the translation of genomics to personalized medicine.Broad phenotypic cross-resistance to elvitegravir in HIV-infected patients failing on raltegravir-containing regimens.HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients.HIV-1 B-subtype capsid protein: a characterization of amino acid's conservation and its significant association with integrase signatures.Molecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors.Natural polymorphisms of HIV-1 subtype-C integrase coding region in a large group of ARV-naïve infected individuals.HIV-1 integrase strand-transfer inhibitor resistance in southern Taiwan.Integrase Strand Transfer Inhibitor Resistance Mutations in Antiretroviral Treatment-naïve Patients in Korea: a Prospective, Observational Study.Prevalence of resistance to integrase strand-transfer inhibitors (INSTIs) among untreated HIV-1 infected patients in Morocco.
P2860
Q28088514-04D73958-88E7-4A4B-B009-CE9EA27DCE47Q28533830-6801E490-0AE9-4721-AE10-E41CED610DF2Q34426605-D976522A-59B2-48D6-B9A9-421FF5C9BB1FQ34520239-39726005-184B-4329-A146-5E98E7582133Q34597650-F151DFF0-6FFC-4742-B87C-32D9E7B0519FQ35114874-6C09427B-1B63-45A3-9EF9-CDB6C81BA9FFQ35134947-1B548251-9D94-46A3-A02C-2603FC236E5AQ35557318-CD828229-B8DD-4752-B6E4-76CB0D199BA1Q36022923-506796FF-D6C0-4FC5-A75E-933C3DE2EA5BQ36266898-5624FC3D-3B24-4FB8-8ED7-5E3B2C0ECE82Q36284159-C96150D2-A7AD-4F19-98FD-DFB12F5D1167Q37364062-69FCCA53-8054-4342-A444-13A989AE9605Q38002011-AD14D559-C126-44B9-A968-00A952C5FEAAQ38035239-CF3D4379-C86A-4901-822D-E050FA5C1C8EQ42060329-15CA1F3E-3EF7-4C37-881F-DBDC0CF309D8Q42094831-F8D0429C-6F6C-4D3F-9DE8-1146D721AEEBQ42240376-2924B65B-227B-4F66-9EC2-0D7E7C4469A2Q47130258-EEE93AE7-FE37-4D48-9AE9-E0F10B62C4ABQ51039642-F5C832FB-9D17-42F6-B5D9-CDD37379EC5BQ55060074-47E92237-4743-4BA4-8832-3A6B66BB91B4Q55257534-927E2216-451D-4722-AEA3-822B79FD5A1CQ55446383-518A4B03-EFD4-4DCF-9A16-3A8830306E59
P2860
Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Specific HIV-1 integrase polym ...... naive to integrase inhibitors.
@en
Specific HIV-1 integrase polym ...... naive to integrase inhibitors.
@nl
type
label
Specific HIV-1 integrase polym ...... naive to integrase inhibitors.
@en
Specific HIV-1 integrase polym ...... naive to integrase inhibitors.
@nl
prefLabel
Specific HIV-1 integrase polym ...... naive to integrase inhibitors.
@en
Specific HIV-1 integrase polym ...... naive to integrase inhibitors.
@nl
P2093
P2860
P50
P356
P1476
Specific HIV-1 integrase polym ...... naive to integrase inhibitors.
@en
P2093
Anna Artese
Carlo-Federico Perno
Isabelle Malet
Roberta D'Arrigo
Salvatore Dimonte
Valentina Svicher
Vincent Calvez
P2860
P304
P356
10.1093/JAC/DKQ326
P407
P50
P577
2010-09-03T00:00:00Z